TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 5 | 8 | 16 | 44 | 47 | 27 | 25 |
| S | %wins | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/17 16:35 | 8/4/17 | SCMP | Sucampo Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Bryan Jones W. | MD | O | Sr. Vice | P | 50 | 10.60 | 0 | 5 | New | 5 | D | |||||||||||||||
3/31/15 16:57 | 3/30/15 | SUPN | Supernus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Bryan Jones W. | MD | O | VP of Bu | M.d | 17 | 2.56 | 11 | 7 | 11 | 68 | D | 109 | 38 | 42 | 36 | 35 | 18 | 3 | 10 | 6 | 3 | 9 | 36 | 21 | 25 |
3/31/15 16:57 | 3/30/15 | SUPN | Supernus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Bryan Jones W. | MD | O | VP of Bu | S.d | -81 | 12.02 | 11 | -7 | -9 | 68 | D | 109 | 38 | 42 | 36 | 35 | 18 | 3 | 10 | 6 | 3 | 9 | 36 | 21 | 25 |
3/26/15 17:33 | 3/24/15 | SUPN | Supernus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Bryan Jones W. | MD | O | VP of Bu | M.d | 6 | 3.35 | 10 | 2 | 3 | 68 | D | 81 | 23 | 29 | 20 | 25 | 8 | -4 | -6 | 4 | 13 | 23 | 52 | 73 | 29 |
3/26/15 17:33 | 3/24/15 | SUPN | Supernus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Bryan Jones W. | MD | O | VP of Bu | S.d | -23 | 12.00 | 10 | -2 | -3 | 68 | D | 81 | 23 | 29 | 20 | 25 | 8 | -4 | -6 | 4 | 13 | 23 | 52 | 73 | 29 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |